Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8204 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.8204 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.8202 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7624 |
Intermediate Similarity |
NPD6765 |
Approved |
0.75 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7459 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7446 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7446 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7443 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7327 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7243 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7191 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7191 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7175 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7128 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7121 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7114 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7111 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7088 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7079 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7052 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7039 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7033 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7022 |
Intermediate Similarity |
NPD37 |
Approved |
0.7017 |
Intermediate Similarity |
NPD919 |
Approved |
0.7015 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7011 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6977 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6961 |
Remote Similarity |
NPD3749 |
Approved |
0.695 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.695 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD920 |
Approved |
0.6915 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6912 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6912 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6912 |
Remote Similarity |
NPD7801 |
Approved |
0.6906 |
Remote Similarity |
NPD3882 |
Suspended |
0.6904 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6904 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6897 |
Remote Similarity |
NPD7236 |
Approved |
0.6872 |
Remote Similarity |
NPD7411 |
Suspended |
0.6851 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD1247 |
Approved |
0.6848 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6837 |
Remote Similarity |
NPD6535 |
Approved |
0.6837 |
Remote Similarity |
NPD6534 |
Approved |
0.6829 |
Remote Similarity |
NPD1049 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD2533 |
Approved |
0.6818 |
Remote Similarity |
NPD2532 |
Approved |
0.6818 |
Remote Similarity |
NPD2534 |
Approved |
0.6818 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6814 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6804 |
Remote Similarity |
NPD8435 |
Approved |
0.6804 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD7239 |
Suspended |
0.6796 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6791 |
Remote Similarity |
NPD7473 |
Discontinued |
0.678 |
Remote Similarity |
NPD6273 |
Approved |
0.6777 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6777 |
Remote Similarity |
NPD7907 |
Approved |
0.6766 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6757 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6742 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.674 |
Remote Similarity |
NPD1934 |
Approved |
0.6733 |
Remote Similarity |
NPD7680 |
Approved |
0.6723 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6718 |
Remote Similarity |
NPD8360 |
Approved |
0.6718 |
Remote Similarity |
NPD8361 |
Approved |
0.6706 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6705 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6703 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.67 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD4665 |
Approved |
0.6682 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3226 |
Approved |
0.6667 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD7930 |
Approved |
0.6649 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.663 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD2800 |
Approved |
0.6628 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6627 |
Remote Similarity |
NPD7319 |
Approved |
0.6615 |
Remote Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD5763 |
Approved |
0.6609 |
Remote Similarity |
NPD5762 |
Approved |
0.6609 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6601 |
Remote Similarity |
NPD3057 |
Approved |
0.6596 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6591 |
Remote Similarity |
NPD3750 |
Approved |
0.6591 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD7999 |
Approved |
0.6584 |
Remote Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD4107 |
Approved |
0.6571 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6569 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6554 |
Remote Similarity |
NPD6190 |
Approved |
0.6553 |
Remote Similarity |
NPD7583 |
Approved |
0.6553 |
Remote Similarity |
NPD7584 |
Approved |
0.6552 |
Remote Similarity |
NPD6100 |
Approved |
0.6552 |
Remote Similarity |
NPD2796 |
Approved |
0.6552 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6552 |
Remote Similarity |
NPD6099 |
Approved |
0.6538 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6536 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6534 |
Remote Similarity |
NPD1243 |
Approved |
0.6534 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD2801 |
Approved |
0.6522 |
Remote Similarity |
NPD7585 |
Approved |
0.652 |
Remote Similarity |
NPD2972 |
Approved |
0.652 |
Remote Similarity |
NPD3533 |
Approved |
0.6519 |
Remote Similarity |
NPD1653 |
Approved |
0.6517 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6514 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6494 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6494 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6494 |
Remote Similarity |
NPD3748 |
Approved |
0.6471 |
Remote Similarity |
NPD7095 |
Approved |
0.6471 |
Remote Similarity |
NPD4482 |
Phase 3 |
0.6465 |
Remote Similarity |
NPD8366 |
Approved |
0.6455 |
Remote Similarity |
NPD5710 |
Approved |
0.6455 |
Remote Similarity |
NPD5711 |
Approved |
0.6455 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6452 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.6452 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.6446 |
Remote Similarity |
NPD7507 |
Approved |
0.6441 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6436 |
Remote Similarity |
NPD8485 |
Approved |
0.6433 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6433 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD5676 |
Approved |
0.6424 |
Remote Similarity |
NPD8328 |
Phase 3 |
0.6422 |
Remote Similarity |
NPD8491 |
Approved |
0.642 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.642 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.642 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.642 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.642 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6416 |
Remote Similarity |
NPD1933 |
Approved |
0.6412
|
Remote Similarity |
NPD6832 |
Phase 2 |